Company research

Alpha Teknova, Inc. Common Stock (TKNO) stock fundamentals

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary

As of 2026-10-09

Exchange
XNAS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Read this company snapshot

Step 1 of 3

Daily valuation snapshot

Alpha Teknova, Inc. Common Stock: source evidence dated 2026-10-09.

Daily close (USD)
$8.84
Market capitalization (USD)
$474,604,094.64
Price / earnings (TTM)
Not reported
Price / book
7.58
What you should see

The source values and product destination above identify the example to inspect.

Step 2 of 3

What business is this, and what does its dated valuation mean?

Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.

Daily valuation dataset and column definitions
What you should see

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Step 3 of 3

Research TKNO in the app

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Research TKNO in the app
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Company overview

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Daily valuation snapshot

See the complete daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing TKNO with another company.

Daily close (USD)$8.84
Market capitalization (USD)$474,604,094.64
Price / earnings (TTM)Not reported
Price / book7.58

Read TKNO's valuation metrics

  1. Company size

    Alpha Teknova, Inc. Common Stock's recorded market capitalization is $474,604,094.64. It measures the market value of the company's equity, rather than its revenue or cash balance.

  2. Price relative to earnings

    P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.

  3. Price relative to book equity

    TKNO's recorded price-to-book ratio is 7.58. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.

Research Alpha Teknova, Inc. Common Stock with Aurora

Use the snapshot above to ask a specific question about TKNO. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow TKNO's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.